ADIPOQ and cancer: Adiponectin can downregulate the expression of ER-α through the HO-1 signaling pathway, thereby blocking the activation of ER-α induced by leptin, blocking the formation of leptin inflammasomes, inhibiting the effect of leptin in promoting tumor growth, and suppressing cancer (160).